Located on the Tufts University Medford, MA campus, this new donor center will enable delivery of fresh blood, leukopaks, and buffy coats for COVID-19, cell, and gene therapy research within hours of collection
BioIVT’s acquisition of Clinical Trial Laboratory Services (CTLS) and its London donor center is enabling this rapid turnaround time for high quality blood-derived immune cells for cell and gene therapy research
BioIVT now offers unique and proprietary bioengineered micro-liver platforms for use in environmental testing, preventive care, and product development in the pharmaceutical and biopharmaceutical, diagnostic, cosmetics, and chemical industries